Literature DB >> 2831453

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections.

J F Jones1, S Shurin, C Abramowsky, R R Tubbs, C G Sciotto, R Wahl, J Sands, D Gottman, B Z Katz, J Sklar.   

Abstract

Fatal T-cell lymphomas developed in three patients with a chronic illness manifested by fever, pneumonia, dysgammaglobulinemia, hematologic abnormalities, and extraordinarily high titers of antibody to the Epstein-Barr virus (EBV) capsid antigen (greater than 10,000) and early antigen (greater than 640) but low titers to the EBV nuclear antigen (less than or equal to 40). To understand the pathogenesis of these tumors better, we determined the immunophenotype of the tumor cells and analyzed tumor-cell DNA for EBV genomes and for lymphoid-cell gene rearrangements. More than 80 percent of the cells in tumors had an activated helper T-cell phenotype (T4, T11, la positive). The EBV genome was found by in situ hybridization in tumor tissue from each patient. Southern blot assay of DNA digests from one patient showed the same pattern as that of the EBV-infected marmoset line, B95-8. DNA digests from two patients showed a monoclonal proliferation of T cells determined on the basis of uniform T-cell-receptor gene rearrangements and a single band for the joined termini of the EBV genome. We conclude that EBV may infect T cells and contribute to lymphomas in selected patients with severe EBV infections.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831453     DOI: 10.1056/NEJM198803243181203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  129 in total

1.  Characterization of the expanded T cell population in infectious mononucleosis: apoptosis, expression of apoptosis-related genes, and Epstein-Barr virus (EBV) status.

Authors:  C S Verbeke; U Wenthe; W F Bergler; H Zentgraf
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  Preferential localization of the Epstein-Barr virus (EBV) oncoprotein LMP-1 to nuclei in human T cells: implications for its role in the development of EBV genome-positive T-cell lymphomas.

Authors:  Jingwu Xu; Ali Ahmad; José Menezes
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification.

Authors:  Ichiro Yonese; Chizuko Sakashita; Ken-Ichi Imadome; Tohru Kobayashi; Masahide Yamamoto; Akihisa Sawada; Yoshinori Ito; Noriko Fukuhara; Asao Hirose; Yusuke Takeda; Masanori Makita; Tomoyuki Endo; Shun-Ichi Kimura; Masataka Ishimura; Osamu Miura; Shouichi Ohga; Hiroshi Kimura; Shigeyoshi Fujiwara; Ayako Arai
Journal:  Blood Adv       Date:  2020-07-14

4.  Epstein-Barr and human immunodeficiency viruses in acquired immunodeficiency syndrome-related primary central nervous system lymphoma.

Authors:  S Morgello
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

5.  Detection of Epstein-Barr virus genome in Ki-1 (CD30)-positive, large-cell anaplastic lymphomas using the polymerase chain reaction.

Authors:  C W Ross; J A Schlegelmilch; T M Grogan; L M Weiss; B Schnitzer; C A Hanson
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

Review 6.  Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

Authors:  Lingyun Geng; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

7.  A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

Authors:  Susan P Perrine; Olivier Hermine; Trudy Small; Felipe Suarez; Richard O'Reilly; Farid Boulad; Joyce Fingeroth; Melissa Askin; Arthur Levy; Steven J Mentzer; Massimo Di Nicola; Alessandro M Gianni; Christoph Klein; Steven Horwitz; Douglas V Faller
Journal:  Blood       Date:  2006-11-21       Impact factor: 22.113

8.  Immunohistochemical demonstration of different latent membrane protein-1 epitopes of Epstein-Barr virus in lymphoproliferative diseases.

Authors:  N M Jiwa; J J Oudejans; D F Dukers; W Vos; A Horstman; P van der Valk; J M Middledorp; J M Walboomers; C J Meijer
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

9.  Stress-related Epstein-Barr virus reactivation.

Authors:  Omer Coskun; Kenan Sener; Selim Kilic; Hakan Erdem; Halil Yaman; Ahmet Bulent Besirbellioglu; Hanefi Cem Gul; Can Polat Eyigun
Journal:  Clin Exp Med       Date:  2009-09-25       Impact factor: 3.984

Review 10.  Severe chronic active Epstein-Barr virus infection syndrome.

Authors:  M Okano; S Matsumoto; T Osato; Y Sakiyama; G M Thiele; D T Purtilo
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.